PRKCA and head and neck squamous cell carcinoma: Evaluation of PRKCA mRNA expression in HNSCC subgroups, based on clinicopathological features in the UALCAN database, revealed positive correlation for stage I vs. II, stage I vs. IV, and stage III vs. IV (Figure 3).